Example: Heart Attack

Search clinical trials for: Flumazenil

Total 21 results

  • NCT03462641
    Completed
    Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm
    Conditions: Parkinson Disease
  • NCT04308954
    Terminated
    Neuroimaging GABA Physiology in Fragile X Syndrome
    Conditions: Fragile X Syndrome (FXS), Idiopathic Intellectual Developmental Disorder (IDD)
  • NCT02899156
    Terminated
    Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Exposure
    Conditions: Hypoactive Delirium
  • NCT02048969
    Withdrawn
    Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
    Conditions: Hepatic Encephalopathy, Liver Cirrhosis
  • NCT03440112
    Recruiting
    Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
    Conditions: Parkinson Disease
  • NCT04329585
    Recruiting
    GABA Antagonist to Improve Reversal of Anesthesia With High-density EEG Surveillance
    Conditions: Moderate Sedation, Colonoscopy
  • NCT03743805
    Unknown status
    Rapid Reversal of CNS-Depressant Drug Effect Prior to Brain Death Determination
    Conditions: Brain Death, Anoxic Brain Injury, Cardiac Arrest, Sedative Intoxication, Narcotic Intoxication
  • NCT00262639
    Completed
    Prometa Protocol for Alcohol Dependence
    Conditions: Alcohol Dependence
  • NCT03825601
    Not yet recruiting
    PET With [18F]Flumazenil as an Index of Neurodegeneration in MS
    Conditions: Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis
  • NCT01183312
    Completed
    Flumazenil for the Treatment of Primary Hypersomnia
    Conditions: Hypersomnia, Primary Hypersomnia, Idiopathic Hypersomnia, Narcolepsy Without Cataplexy
  • NCT01904487
    Completed
    Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence
    Conditions: Alcoholism
  • NCT01651520
    Unknown status
    Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis
    Conditions: Multiple Sclerosis
  • NCT00000246
    Completed
    Rapid Benzodiazepine Detoxification Using Flumazenil - 1
    Conditions: Substance-Related Disorders
  • NCT02690389
    Completed
    Electro-acupuncture and Flumazenil's Effect on Sedation
    Conditions: Acupuncture, General Anaesthesia, Sedation
  • NCT01655914
    Completed
    Safety and Pharmacokinetic Study of Sublingual Flumazenil (CRLS035) in Healthy Adults
    Conditions: Insomnia
  • NCT01071889
    Completed
    Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults
    Conditions: Healthy
  • NCT02157428
    Completed
    Effect of Flumazenil on Recovery From General Anesthesia With Isoflurane
    Conditions: Adverse Effect of Other General Anesthetics
  • NCT00997087
    Terminated
    A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder
    Conditions: Obsessive Compulsive Disorder
  • NCT00681746
    Completed
    Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280
    Conditions: Anxiety
  • NCT00681720
    Completed
    Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325
    Conditions: Anxiety
  • NCT00695630
    Completed
    Flumazenil Reversal of Oral Triazolam
    Conditions: Dental Anxiety
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations